BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31536165)

  • 1. The emerging role of regulatory T cells following lung transplantation.
    Gauthier JM; Harrison MS; Krupnick AS; Gelman AE; Kreisel D
    Immunol Rev; 2019 Nov; 292(1):194-208. PubMed ID: 31536165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Basic Research Progress on Treg-Induced Immune Tolerance in Liver Transplantation.
    Ni X; Wang Q; Gu J; Lu L
    Front Immunol; 2021; 12():535012. PubMed ID: 34093514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in kidney disease and transplantation.
    Hu M; Wang YM; Wang Y; Zhang GY; Zheng G; Yi S; O'Connell PJ; Harris DC; Alexander SI
    Kidney Int; 2016 Sep; 90(3):502-14. PubMed ID: 27263492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time elapsed after transplantation influences the relationship between the number of regulatory T cells in lung allograft biopsies and subsequent acute rejection episodes.
    Krustrup D; Iversen M; Martinussen T; Andersen CB
    Transpl Immunol; 2014 Jun; 31(1):42-7. PubMed ID: 24801207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Control and prevention of kidney transplant rejection: the role and possibilities for the clinical use of regulatory T-cells in transplantation].
    Mukhin VE; Polyakova YV; Kaabak MM; Babenko NN; Bryzgalina EV; V'yunkova YN
    Khirurgiia (Mosk); 2019; (9):80-85. PubMed ID: 31532171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
    Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
    Front Immunol; 2019; 10():43. PubMed ID: 30804926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.
    Sánchez-Fueyo A; Strom TB
    Gastroenterology; 2011 Jan; 140(1):51-64. PubMed ID: 21073873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.
    Zhou W; Zhou X; Gaowa S; Meng Q; Zhan Z; Liu J; Li J; Fan H; Liu Z
    Transplantation; 2015 Jul; 99(7):1356-64. PubMed ID: 25856405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of regulatory T cells in liver transplantation.
    Beyzaei Z; Shojazadeh A; Geramizadeh B
    Transpl Immunol; 2022 Feb; 70():101512. PubMed ID: 34871717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells in rejection and tolerance of solid organ allografts.
    Benichou G; Yamada Y; Aoyama A; Madsen JC
    Curr Opin Organ Transplant; 2011 Feb; 16(1):47-53. PubMed ID: 21157342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Blood Regulatory T Cells Are Diminished in Kidney Transplant Patients With Chronic Allograft Nephropathy.
    Carmona-Escamilla MA; Queipo G; García-Mosqueda LA; García-Covarrubias L; Fonseca-Sánchez MA; Villanueva-Ortega E; Prieto P; Lascurain R
    Transplant Proc; 2018 Mar; 50(2):444-448. PubMed ID: 29579824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go?
    Battaglia M
    Transpl Int; 2010 Aug; 23(8):761-70. PubMed ID: 20553440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characteristics of renal transplant tolerance in humans.
    Lu J; Zhang X
    Mol Immunol; 2016 Sep; 77():71-8. PubMed ID: 27479171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant trials with Tregs: perils and promises.
    Tang Q; Vincenti F
    J Clin Invest; 2017 Jun; 127(7):2505-2512. PubMed ID: 28665300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the use of regulatory T cells in allotransplantation: recent advances and future perspectives.
    Baum CE; Mierzejewska B; Schroder PM; Khattar M; Stepkowski S
    Expert Rev Clin Immunol; 2013 Dec; 9(12):1303-14. PubMed ID: 24215417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts.
    Abe Y; Urakami H; Ostanin D; Zibari G; Hayashida T; Kitagawa Y; Grisham MB
    PLoS One; 2009 Nov; 4(11):e7840. PubMed ID: 19956764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.